European Commission is offering no meaningful solutions for equitable access

The signatories to the letter point out that communications from the Commission to the World Trade Organization’s TRIPS Council offer no meaningful solutions for equitable access to vaccines & other health technologies to combat the COVID-19 pandemic.

Read the full text of the letter, and the list of signatories below, or download the PDF.

We, the undersigned, would like to express our serious concerns regarding the position of the European Commission on efforts to increase access to COVID-19 vaccines, treatments, and other medical goods by means of a temporary waiver of certain provisions of the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement.

For over a year, the pandemic has been ravaging societies and economies. Meanwhile, disparities in access to vaccines and other health technologies have resulted in uneven paths of recovery, with many countries yet to see any light at the end of the tunnel. The proposal from India and South Africa on a TRIPS waiver, submitted in October 2020, and the revised decision text presented in May, attempt to address inequities in access to critical commodities for controlling COVID-19. They do so by expeditiously facilitating freedom to scale up production and diversify supply options. This proposal is now co-sponsored by 63 World Trade Organization (WTO) Members and supported by more than 100 Members.

In the last nine months, the proposal has been discussed extensively and the co-sponsors have responded to questions and requests from WTO Members, including the European Union (EU). The proposal has received massive global support and is backed by United Nations agencies including the World Health Organization and UNAIDS, the scientific community, medical associations, trade unions, community and faith-based leaders, national and regional lawmakers, former presidents, prime ministers and Nobel laureates.

Within the EU, Member State legislatures in Spain, France and Italy have been vocal in supporting motions for a waiver at the WTO. Furthermore, the European Parliament recently approved a resolution “calling for support for proactive, constructive, and text-based negotiations for a temporary waiver of the WTO TRIPS Agreement, aiming to enhance global access to affordable COVID19-related medical products and to address global production constraints and supply shortages”[1].

On 4th June 2021, the European Commission submitted communication IP/C/W/680[2] to the Council for TRIPS titled “Urgent Trade Policy responses to the COVID-19 crisis: Intellectual Property”. This was followed by another communication on 18th June proposing a declaration on the TRIPS Agreement and Public Health in the circumstances of a pandemic (IP/C/W/681)[3].

The communications presented by the European Commission to the WTO are, in our view, devoid of any useful solutions, despite this being a critical point at which the WTO should be making decisive and concrete contribution to ensure timely, equitable global access to vaccines, treatments, diagnostics, and other COVID-19 health technologies and goods.

The clarifications contained in the communications are inadequate as they address issues that have never been in dispute and that are clearly provided for in the text of Article 31, and Article 31bis of the TRIPS Agreement and the Doha Declaration on TRIPS and Public Health.[4] These “pseudo-proposals” will create nothing but confusion and will simply serve to distract and delay discussion on the TRIPS waiver proposal.

The communications also fail to address the major underlying concern with respect to compulsory licensing – that its “case-by-case” or “product-by-product” approach is limiting during the pandemic and that this approach means additional tools are needed to overcome IP barriers.[5] In fact, historically the EU, the US and other high-income countries have discouraged developing countries from using compulsory licensing. Further, the requirements of Article 31bis of the TRIPS Agreement have rendered the mechanism unworkable to generally address access to medicines, even more so during a pandemic.

In addition, the communications’ focus on compulsory licensing is short-sighted in that it does not address the broader challenges posed by intellectual property rights, such as trade secrets, industrial designs and copyright that are needed to produce vaccines and other health technologies.

The disparity in access between high-income and lower-income countries is vast. Latest data shows that high-income countries that represent only 16% of the world population have fully vaccinated 28.5% of their populations, while a mere 0.1% of people in low-income countries and on average about 7.8% of middle-income countries have been fully vaccinated[6]. Similarly access to testing, therapeutics and other health technologies remains a challenge in developing countries. There is an urgent need to scale up and diversify production of vaccine and other critical technologies.

The EU’s communications cannot be considered as an alternative to the waiver proposal to address the pandemic access issues because they do not respond to any of the elements and concerns raised by the co-sponsors of the TRIPS waiver proposal and introduces text that may instead undermine the use of existing TRIPS flexibilities. In fact, we note that the TRIPS Waiver is based on a specific process under Article IX of the WTO.

To conclude:

• We urge the EU Member States to request that the European Commission reconsiders its communications to the TRIPS Council given that they do not offer any meaningful solutions to the issue of equitable access and may instead undermine TRIPS flexibilities.

• We demand that the EU does not disrupt the discussions on the TRIPS waiver proposal. The EU must acknowledge the European Parliament’s opinion and constructively engage in the text-based negotiations of the TRIPS waiver proposal (IP/C/W/669/Rev.1), ensuring the will of European citizens and billions of people around the world is heard and realized.

Sincerely,

Signatory organizations

International Organizations

1. African Centre for Global Health & Social Transformation (ACHEST)

2. Action against AIDS Germany

3. ActionAid Nederland

4. AIDS Action Europe

5. Amnesty International

6. APN+

7. Asia Pacific Forum on Women, Law and Development

8. Asian Health Institute

9. Association for Proper Internet Governance

10. Australian Arts Trust / Music Trust

11. Brot füer die Welt

12. BUKO Pharma-Kampagne

13. Centre for Health and Resource Management

14. CHISA

15. Comitato ICE NOPROFITONPANDEMIC Cosenza

16. Consiglio Nazionale delle Ricerche (Italy)

17. Corporate Europe Observatory (CEO)

18. COVID Advocates Advisory Board

19. Development Alternatives with Women for a New Era (DAWN)

20. Drug Action Forum – Karnataka

21. East African Health Platform

22. Education International

23. European African Treatment Advocates Network

24. European AIDS Treatment Group

25. European Citizens’ Initiative No Profit on Pandemic

26. European Federation of Public Service Unions (EPSU)

27. Farmamundi

28. Feminist Task Force

29. Focus on the Global South

30. Fondation Eboko

31. Fondazione Lelio e Lisli Basso Onlus

32. Foundation for Integrative AIDS Research (FIAR)

33. Frontline AIDS

34. Fundación Salud por Derecho

35. Gandhi Development Trust

36. GenderCC SA

37. Global Health Advocates / Action Santé Mondiale

38. Global People’s Health Movement

39. Governance Links

40. GRAIN

41. Health Action International (HAI)

42. Health Action International Asia Pacific

43. Health Alliance International

44. Health GAP

45. HIV Legal Network (Canada)

46. Human Rights Watch

47. IFARMA Foundation

48. Latin American Institute for La Paz and Citizenship (ILAPYC)

49. IndustrialALL Global Union

50. Institute for Agriculture and Trade Policy

51. Institute for Economic Research on Innovation

52. Interfaith Center on Corporate Responsibility

53. International Federation of Anthroposophic Medical Associations

54. International Treatment Preparedness Coalition (ITPC)

55. International Union of Food, Agricultural,Hotel, Restaurant, Catering, Tobacco and Allied Workers Associations (IUF)g

56. International Women’s Rights Action Watch Asia Pacific (IWRAW Asia Pacific)

57. IT for Change

58. ITPC-LATCA

59. Kazan Medical University

60. KEI Europe

61. Médecins du Monde

62. Médecins Sans Frontières (MSF) Access Campaign

63. Medical Mission Institute

64. Medicina Democratica Onlus

65. Medicusmundi

66. NGO Santé Diabète

67. Oxfam International

68. Pan-African Treatment Access Movement

69. Peoples Health Movement

70. People’s Health Movement (PHM) Europe

71. Pertubuhan Kebajikan Intan Zon Kehidupan

72. Pharmaceutical Accountability Foundation

73. PHM – Zambia

74. PT Foundation

75. Public Service International (PSI)

76. Right2cure/Dirittoallacura Italia

77. Salud y Fármacos

78. Sisters of Charity Federation

79. Society for International Development (SID)

80. Solidarité Agissante pour Développement Familial (SADF)

81. South Asia Alliance for Poverty Eradication (SAAPE)

82. Southern African Programme on Access to Medicines and Diagnostics (SAPAM)

83. The European Network against Commercialisation of Healthcare and Social Protection

84. The Global Network of People living with HIV (GNP+)

85. Third World Network

86. Transnational Institute

87. Transparency International Global Health

88. Treatment Action Group

89. UNI Global Union

90. University College Dublin

91. Viva Salud

92. WeMove Europe

93. Womankind Worldwide

94. World Vision Deutschland e.V.

95. Yolse, Santé Publique et Innovation

National Organizations

• Access to Medicines Ireland

• Acción Internacional para la Salud (AIS PERU)

• ActionAid Ireland

• ADSP-IB Associació per a la Defensa de la Sanitat Pública de les Illes Balears

• Africa Japan Forum

• Alianza por la Solidaridad-ActionAid

• Alliance Women of Advocating for Change (AWAC)

• All India Drug Action Network

• Ashar Alo Society

• Asociación de Mujeres Gente Nueva-AMUGEN-

• Asociación por un Acceso Justo al Medicamento

• Associação Brasileira Interdisciplinar de AIDS (ABIA)

• Association de Lutte Contre la Dépendance

• Association For Promotion Sustainable Development

• Australian Fair Trade and Investment Network

• Belgia Center for Pharmacotherapeutical Information

• Bolivian Commitee for Consumers Protección CODEDCO

• Canadian Centre for Policy Alternatives (CCPA)

• Cancer Alliance, South Africa

• Coalition of Women Living with HIV and AIDS

• Center for Health, Human Rights and Development (CEHURD)

• Child Way Uganda

• CNCD-11.11.11

• Coalition for Health Promotion and Social Development (HEPS Uganda)

• Coalizione Italiana Libertà e i Diritti civili (CILD)

• COAST Trust

• Consumer Association the Quality of Life-EKPIZO

• Consumers’ Association of Penang

• Cooperative and Policy Alternative Center

• Coordinadora de Organizaciones para el Desarrollo

• Crisis Home

• Dandora Community Aids support Association (DACASA)

• Ecologistas en Acción

• Equidad de Género: Ciudadanía, Trabajo y Familia

• Fairwatch

• Federación de Asociaciones para la Defensa de la Sanidad Pública

• Focsiv Italian Federation Christian NGOs

• Forum Maranhense Das Respostas Comunitarias de Luta Contra as IST AIDS e Hepatites Virais

• Fórum ONG AIDAS RS

• Foundation for Male Engagement (FOME)

• Friends of the Earth Malaysia

• Fundación Grupo Efecto Positivo (FGEP)

• GeneEthics

• Gestos (soropositividade, comunicação, gênero)

• Grupo de Incentivo à Vida (GIV)

• Grandmothers Advocacy Network

• Grupo de Resistência Asa Branca- GRAB

• Grupo Pela Vidda SP

• Handel Anders Coalitie

• Health Equity Initiatives

• Indonesia AIDS Coalition

• Indonesia for Global Justice

• Initiative for Health & Equity in Society

• Innovations for Development (I4DEV)

• Integrated Social Development Effort (ISDE) Bangladesh

• International Community of Women Living with and affected by HIV- Kenya Chapter

• IPleft

• ItsOurFuture (NZ)

• Just Treatment

• Kamukunji Paralegal Trust (KAPLET)

• Kenya Legal & Ethical Issuse Network on HIV & AIDS

• Kenyan Network of Cancer Organizations

• Khulumani Support Group

• Konsil LSM Indonesia

• Korean Pharmacists for Democratic Society

• Malawi Health Equity Network

• Malawi Network of Religious Leaders Living with or Personally Affected by HIV and AIDS (MANERELA+)

• Malaysian Women’s Action for Tobacco Control and Health

• Milwaukee Fair Trade Coalition

• National Alliance of People’s Movements

• national Alliance of women Human Right defenders

• National Alliance of Women Human Rights Defenders (NAWHRD)

• National Fisheries Solidarity

• New Kashmir Women and Child Welfare Society

• Non-communicable Diseases Alliance Kenya

• Oxfam IBIS

• Pacifc Asia Resource Center (PARC)

• People’s Health Movement (PHM) Korea

• People’s Health Movement-Japan Circle

• Perkumpulan Medialink

• Perkumpulan PRAKARSA

• Pertubuhan Persaudaraan Pesawah Malaysia (PeSAWAH)

• PHM Kenya

• Positive Malaysian Treatment Access & Advocacy Group (MTAAG+)

• Positive Men’s Union (POMU)

• Public Citizen

• Red de Acceso a Medicamentos

• Rural Area Development Programme (RADP)

• Sankalp Rehabilitation Trust

• Southern and East African Trade Institute – South Africa (SEATINI)

• Servicios Ecumenicos para Reconciliation y Reconstruccion

• Sotsium Association

• Southern and Eastern African Trade Information and Negotiations Institute

• Sukaar Welfare Organization

• Tarangini Foundation

• TB Proof

• The Malaysian AIDS Council (MAC}

• The People’s Health Movement South Africa

• Trade Justice Network Canada

• Trade Justice Pilipinas

• Trade Justice Prince Edward Island

• Tusitukirewamu Group Bwaise

• UFRJ

• Uganda Key Populations Consortium Uganda (UKPC)

• University Health Network

• University of Naples Federico II

• We Rise and Prosper (WRAP)

• WEMOS

• Women’s Coalition Against Cancer- WOCACA

• Women’s Probono Initiative (WPI) – Uganda

• Zimbabwe National Network of PLHIV (ZNNP+)

[1] Texts adopted – Meeting the Global Covid-19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and increasing production and manufacturing capacity in developing countries – Thursday, 10 June 2021 (europa.eu)

[2] IP/C/W/680 (wto.org)

[3] IP/C/W/681 (wto.org)

[4] MSF analysis of EU communications to TRIPS Council on COVID-19 IP waiver proposal
https://msfaccess.org/msf-analysis-eu-communications-trips-council-covid-19-ip-waiver-proposal and “Disinformation, Diversion, and Delay: The Real Text of the European Union’s Communication to the WTO TRIPS Council” at http://infojustice.org/archives/43180

[5] Compulsory licenses, the TRIPS waiver and access to COVID-19 medical technologies https://msfaccess.org/compulsory-licenses-trips-waiver-and-access-covid-19-medical-technologies and MSF Technical Brief: Analysis of EU position on compulsory licensing and TRIPS waiver in the COVID-19 pandemic https://msfaccess.org/analysis-eu-position-compulsory-licensing-and-trips-waiver-covid-19-pandemic

[6] https://ourworldindata.org/covid-vaccinations